Logo image of PFSA

PROFUSA INC (PFSA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PFSA - US74319X1081 - Common Stock

0.177 USD
0 (-2.48%)
Last: 12/5/2025, 8:00:00 PM
0.1769 USD
0 (-0.06%)
After Hours: 12/5/2025, 8:00:00 PM
Fundamental Rating

0

Overall PFSA gets a fundamental rating of 0 out of 10. We evaluated PFSA against 187 industry peers in the Health Care Equipment & Supplies industry. PFSA may be in some trouble as it scores bad on both profitability and health. PFSA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PFSA has reported negative net income.
In the past year PFSA has reported a negative cash flow from operations.
PFSA Yearly Net Income VS EBIT VS OCF VS FCFPFSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

The Return On Assets of PFSA (-856.63%) is worse than 97.35% of its industry peers.
Industry RankSector Rank
ROA -856.63%
ROE N/A
ROIC N/A
ROA(3y)-29.82%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PFSA Yearly ROA, ROE, ROICPFSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50 100 -100 150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PFSA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PFSA Yearly Profit, Operating, Gross MarginsPFSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, PFSA has less shares outstanding
PFSA has a worse debt/assets ratio than last year.
PFSA Yearly Shares OutstandingPFSA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
PFSA Yearly Total Debt VS Total AssetsPFSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

PFSA has an Altman-Z score of -28.89. This is a bad value and indicates that PFSA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PFSA (-28.89) is worse than 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -28.89
ROIC/WACCN/A
WACCN/A
PFSA Yearly LT Debt VS Equity VS FCFPFSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

PFSA has a Current Ratio of 0.04. This is a bad value and indicates that PFSA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.04, PFSA is not doing good in the industry: 97.88% of the companies in the same industry are doing better.
A Quick Ratio of 0.04 indicates that PFSA may have some problems paying its short term obligations.
The Quick ratio of PFSA (0.04) is worse than 97.88% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
PFSA Yearly Current Assets VS Current LiabilitesPFSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for PFSA have decreased strongly by -1184.00% in the last year.
EPS 1Y (TTM)-1184%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1906.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PFSA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PFSA Price Earnings VS Forward Price EarningsPFSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PFSA Per share dataPFSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PFSA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PROFUSA INC

NASDAQ:PFSA (12/5/2025, 8:00:00 PM)

After market: 0.1769 0 (-0.06%)

0.177

0 (-2.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-05 2025-12-05
Earnings (Next)03-23 2026-03-23
Inst Owners0.4%
Inst Owner ChangeN/A
Ins Owners9.98%
Ins Owner Change0%
Market Cap11.63M
Revenue(TTM)N/A
Net Income(TTM)-16.81M
AnalystsN/A
Price TargetN/A
Short Float %3.74%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.32
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -856.63%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.82%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -28.89
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1184%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1906.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.62%
OCF growth 3YN/A
OCF growth 5YN/A

PROFUSA INC / PFSA FAQ

Can you provide the ChartMill fundamental rating for PROFUSA INC?

ChartMill assigns a fundamental rating of 0 / 10 to PFSA.


Can you provide the valuation status for PROFUSA INC?

ChartMill assigns a valuation rating of 0 / 10 to PROFUSA INC (PFSA). This can be considered as Overvalued.


Can you provide the profitability details for PROFUSA INC?

PROFUSA INC (PFSA) has a profitability rating of 0 / 10.


What is the financial health of PROFUSA INC (PFSA) stock?

The financial health rating of PROFUSA INC (PFSA) is 0 / 10.